Wei Qing Luo

Harvest Global Investments Ltd. (HGI) is the wholly-owned, Hong Kong-based investment management subsidiary of Harvest Fund Management Co., Ltd. (HFM), an asset management company headquartered in China. Founded in 2008, HGI provides discretionary portfolio management services to their clients, sometimes with the assistance of HFM, serving as the investment adviser to pooled investment vehicles sponsored by other financial firms. They also provide investment advisory services on behalf of sophisticated institutional investors to separately managed accounts.

China International Capital Corp. Ltd. (Broker) (CICC) is the brokerage division of China International Capital Corp. Ltd. which was established in 1995 as a strategic partnership between Chinese and international financial institutions and corporations. Headquartered in Beijing, CICC was the first joint venture investment bank in China. The firm's core business departments were investment banking, capital markets, sales & trading, research, fixed-income and asset management. CICC offers a range of brokerage services to international and domestic institutional and individual investors. In 2007 the firm set up a wholly-owned subsidiary specializing in private equity investments and focusing on buyout opportunities within China.

Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China.

Changsheng Fund Management Co., Ltd. (CFM) is an independent Chinese fund management firm which was established in 1999. The firm's shareholders include Guoyuan Securities Co., DBS Asset Management, a wholly-owned subsidiary of Singapore-based DBS Bank, Anhui Provincial Innovation Investment Co. and Anhui Provincial Investment Group Co., both controlled by the Chinese Government. Based in Beijing with an office in Shanghai, CFM manages mutual funds and contributes to the management of the National Social Security Funds. Their clients are domestic retail investors and international institutions. The firm's culture combines Changsheng's local market knowledge and distribution network with DBS Asset Management's investment and risk management experience.

Manulife TEDA Fund Management Co. Ltd. (Manulife TEDA FM) is the fund management joint venture between Northern International Trust & Investment Co. Ltd. and Manulife Asset Management (Hong Kong) Ltd. Formerly known as ABN AMRO TEDA Fund Management Co. Ltd., the firm was established in 2002 as Tianjin TEDA Investment Holding Co., Ltd. Manulife TEDA FM is located in Beijing and manages a range of open-end funds, including equity, hybrid, bond and currency funds, for individual and institutional customers.

Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China.

University of Washington functions as a College/University. The company is headquartered in Seattle, WA.

American Century Investment Management, Inc. (ACIM) is a SEC-registered investment advisor and mutual fund manager headquartered in Kansas City, Missouri. The firm was founded by James E. Stowers, Jr. in 1958 and is a wholly-owned subsidiary of American Century Cos., Inc. ACIM provides portfolio management services to financial advisors, individual investors and institutional clients.

Zhong Ou Asset Management Co., Ltd. (Zhong Ou AM) is a fund management firm headquartered in Shanghai, China. Formerly known as Lombarda China Fund Management Co., Ltd., the firm was founded in 2006 as a joint venture between UBI, Guodu Securities Co., Ltd., China Private Ventures (Beijing) Ltd. and WinnerKey Investment Co., Ltd. Zhong Ou AM manages mutual funds and provides financial advisory services to both Chinese and global institutional, as well as retail investors.

China Minsheng Jiaye Investment Co., Ltd. engages in corporate investment services. Its activities include investment management, consultancy, real-estate and infrastructure investment. The company was founded on July 15, 2014 and is headquartered in Shanghai, China.

China Asset Management Co., Ltd. (China AMC) is the asset management subsidiary of CITIC Securities Co., Ltd. (SHA: 600030) in China. Headquartered in Beijing, the firm was founded in 1998 and provides a full range of services to domestic and international retail and institutional clients from US, Canada, Korea, Japan, Malaysia, Germany, Hong Kong, Macau and Taiwan, and many more, covering equity, fixed income, money markets, and other financial instruments. In 2017, China AMC has joined the United Nations-supported Principles for Responsible Investment (UNPRI), becoming the first full service asset manager in China to join the organization.

Genfleet Therapeutics (Shanghai), Inc. is a Chinese clinical-stage biotechnology company that focuses on developing novel drug candidates for unmet medical needs in oncology and immunology. The company is based in Shanghai, China, and was founded in 2017 by Jiong Lan and Qiang Lü. The company has built up industry-leading capabilities and expertise in developing both small molecules and biologics since its inception in 2017. Genfleet's proprietary and fully integrated R&D platform highlights multiple cutting-edge products with novel mechanisms and IP. The company's pipeline includes over 10 programs, many of which have entered multi-regional clinical trials across China. Genfleet has completed co-development partnerships with a number of publicly listed companies worldwide. Jiong Lan has been the CEO since 2017.

Ningbo Taikang Pharmaceutical Technology Co. Ltd. is a private company that develops pharmaceutical technology. The company is based in Ningbo, China.

Shanghai Ennovabio Pharmaceuticals Co. Ltd. is a private company that manufactures pharmaceutical products. The company is based in Shanghai, China.

Suzhou Kintor Pharmaceuticals, Inc. engages in the technology research and development, technical services, transfer, and advice of drugs and reagents. The company was founded by Youzhi Tong on March 24, 2009 and is headquartered in Suzhou, China.

Kontour (Xi'an) Medical Technology Co., Ltd. engages in the research and development, production, and sales service of three types of implanted medical devices. Its products include neurosurgery products, cardiothoracic surgery products, neurospine products, and oral implant system. Its products are used in neurosurgery, skull repair, and cardiothoracic surgery. The company was founded by Li Ren Hu, Li Gong Hu and Di Yuan Huang on March 14, 2005 and is headquartered in Xi'an, China.

Beijing Continent Pharmaceutical Co. Ltd. is a commercial-stage biopharmaceutical company committed to the research, development and commercialization of innovative drugs for organ fibrosis for two decades. The firm focuses on idiopathic pulmonary fibrosis (“IPF”) and have gradually broadened therapeutic field and research & development efforts to other areas of organ fibrosis. The company flagship product ETUARY (pirfenidone capsule) was approved in China in 2011 and is among the first three approved drugs for IPF worldwide. The firm has developed a pipeline of additional four innovative drug candidates, and amassed eight-years’ experience of successful commercialization. The company was founded in July 2002 and is headquartered in Beijing, China.

Shanghai CCI Investment Co., Ltd. engages in the provision of capital investment services. Its business scope includes the offering of integrated capital operation platform, such as securities investment, private equity investment, and investment banking services. The company was founded on February 4, 1997 and is headquartered in Shanghai, China.

Jiangxi Rimag Group Co. Ltd. engages in the investment and operation of medical imaging centers, technology development of medical imaging cloud platforms, training of medical imaging talents, and medical imaging industry chain services. The company was founded on October 30, 2014 and is headquartered in Beijing, China.

Founder Securities Co. Ltd. (Invt Mgmt) (FS-IM) is the investment management division of Founder Securities Co. Ltd. (SHA: 601901), which is headquartered in Beijing, China. FS-IM was founded in 2008 and offers securities brokerage, asset management, investment banking and other comprehensive financial services, as well as the securities proprietary and investment services.

Tian Hong Asset Management Co., Ltd. (Tian Hong) is the investment adviser subsidiary of Ant Group Co., Ltd. in China. Headquartered in Tianjin, Tian Hong was founded in 2004 and provides investment advice and investment consultancy services.

China Post & Capital Fund Management Co., Ltd. (CPCFM) is an independent Chinese investment advisory firm which was founded in 2006. Headquartered in Beijing, the firm provides a range of services including fund raising, fund sales, asset management and other business activities as permitted by China Securities Regulatory Commission. They are the investment manager of several open-ended investment funds.

Tysan Foundation Holdings Ltd. engages in the foundation and related works. It provides bored piling, percussive H-piling, socket H-piling and mini-piling, ELS, pile cap, substructure and basement construction, footing works, site formation, ground investigation, landslip preventive and slope works and demolition, in public and private sectors. The company was founded on July 8, 2011 and is headquartered in Hong Kong.

Baring Asset Management (Asia) Ltd. (BAM-Asia) is an asset management firm headquartered in Hong Kong. The firm was founded in 1976 and is a subsidiary of Baring Asset Management (Asia) Holdings Ltd., which is ultimately owned by Massachusetts Mutual Life Insurance Co. in the US. BAM-Asia manages assets locally and distributes their institutional products and managed funds to a range of clients which includes central banks and pension funds. They distribute their retail funds via intermediaries.

Hua Yuan Science & Technology Association is a non-profit organization that was established in 1999. The private company is based in San Jose, CA. The company's main focus is to empower Chinese American entrepreneurs and leaders.

DWS Investments Hong Kong Ltd. (DWS HK) is the wholly-owned, Hong Kong-based asset management subsidiary of DWS Group GmbH & Co KGaA, ultimately held by Deutsche Bank AG (NYSE: DB), a multi-national financial services company headquartered in Germany. DWS HK provides advisory services which include research reports and analysis conducted for listed securities in certain APAC locations and may also include recommendations on transacting such securities. This service is provided to DWS HK’s affiliated advisers, which in turn provide advisory services to their US clients and non-US clients. The firm also provides discretionary investment advisory and management services with respect to separately managed accounts, as well as private equity funds focused on sustainable investments strategies.

Harvest Investments Management Co., Ltd. engages in the provision of investment and asset management services. Its business includes project investment and investment advisory. The company was founded on December 9, 2014 and is headquartered in Beijing, China.

Shanghai Sunshine Capital Management Co. Ltd. is a private equity fund management company based in Shanghai, China. The Chinese company, also known as Taiyu Asset Management Co., Ltd., focuses on stock investment and is a member unit of China Securities Investment Fund Industry Association. Founded in 2015 by Tian Jun Liu, who has been the CEO since then, Taiyu Asset Management adheres to the investment concept of "in-depth rationality and long-term returns" and aims to become a Chinese stock expert with an international perspective, creating long-term stable absolute revenue for investors.

Hui''an Fund Management Co. Ltd. (Hui''an Fund) is an independent Chinese fund management firm which was established in 2016. Headquartered in Beijing, the firm provides a range of fund management services to individual and institutional investors.

China Southern Asset Management Co., Ltd. (CSAM) is an independent Chinese fund management firm which was founded in 1998. Headquartered in Shenzhen, the firm launched China's first listed open-ended fund in 2004 and manages a range of close-ended and open-ended investment funds for institutional clients and private individuals. They are one of the investment managers selected by the Chinese government to manage an institutional mandate for the National Social Security Fund. In 2007, CSAM acquired QDII status (Qualified Domestic Institutional Investors) allowing them to invest in the overseas capital markets under the foreign exchange control system in China. They announced the launching, in cooperation with US-based Mellon Financial Corporation, of their first QDII investment fund in 2007.